| pubmed-article:2356156 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2356156 | lifeskim:mentions | umls-concept:C0024660 | lld:lifeskim |
| pubmed-article:2356156 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:2356156 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:2356156 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:2356156 | lifeskim:mentions | umls-concept:C0039082 | lld:lifeskim |
| pubmed-article:2356156 | lifeskim:mentions | umls-concept:C1882443 | lld:lifeskim |
| pubmed-article:2356156 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2356156 | pubmed:dateCreated | 1990-7-26 | lld:pubmed |
| pubmed-article:2356156 | pubmed:abstractText | Yang et al. (14) have isolated from mammalian brain an octapeptide FLFQPQRF-NH2 (F-8-F-NH2) with certain antiopiate properties. Third ventricular injection of 2 micrograms of this peptide together with the aminopeptidase inhibitor bestatin precipitated an opiate-withdrawal syndrome in morphine-dependent but not in nondependent rats. Third ventricular injection in nondependent rats of 15 micrograms of the peptide together with bestatin induced a morphine-withdrawal-like behavioral syndrome. This syndrome was not produced by injection of bestatin or saline vehicle alone and was preventable by injection of 3.5 mg/kg morphine sulphate SC. | lld:pubmed |
| pubmed-article:2356156 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2356156 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2356156 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2356156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2356156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2356156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2356156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2356156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2356156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2356156 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2356156 | pubmed:issn | 0196-9781 | lld:pubmed |
| pubmed-article:2356156 | pubmed:author | pubmed-author:LakeJ RJR | lld:pubmed |
| pubmed-article:2356156 | pubmed:author | pubmed-author:BrownS LSL | lld:pubmed |
| pubmed-article:2356156 | pubmed:author | pubmed-author:McKEYB VBV | lld:pubmed |
| pubmed-article:2356156 | pubmed:author | pubmed-author:DoughertyT... | lld:pubmed |
| pubmed-article:2356156 | pubmed:author | pubmed-author:FowlerD EDE | lld:pubmed |
| pubmed-article:2356156 | pubmed:author | pubmed-author:HammondM VMV | lld:pubmed |
| pubmed-article:2356156 | pubmed:author | pubmed-author:LeyvaJ EJE | lld:pubmed |
| pubmed-article:2356156 | pubmed:author | pubmed-author:PrascoP EPE | lld:pubmed |
| pubmed-article:2356156 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2356156 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:2356156 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2356156 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2356156 | pubmed:pagination | 277-80 | lld:pubmed |
| pubmed-article:2356156 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:meshHeading | pubmed-meshheading:2356156-... | lld:pubmed |
| pubmed-article:2356156 | pubmed:articleTitle | FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. | lld:pubmed |
| pubmed-article:2356156 | pubmed:affiliation | University of Houston-Clear Lake, TX 77058. | lld:pubmed |
| pubmed-article:2356156 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2356156 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
